Videos

Jim Mellon and Al Chalabi have written a new book "Juvenescence: Investing in the Age of Longevity" in which they alert readers to the amazing science of Juvenescence, to the prospect of living much longer than most people expect, and also to the ways in which we can prosper as investors in this new era of longevity. In this video, Jim discusses the book's content and why you should read it. Find out more and order online at www.juvenescence-book.com.

"You're going to live till your 120," explains my guest today on Stuff That Interests Me - one of Britain's most successful investors, Jim Mellon. It's all thanks to a combination of lifestyle, new drugs, and new technologies. What are you going to do with all your time? The next great investment trend will be around the fact that we are all going to love a lot longer. Find out more in the this fascinating interview. Juvenescence - Investing in the Age of Longevity is available from all good bookstores and at https://www.juvenescence-book.com/

On 20th June 2017, Master Investor, in partnership with Edition Group, hosted a thought-leadership panel discussion on health care investment trends in the UK. The panel featured: - Jim Mellon: Legendary investor and author of the book “Juvenescence” about investing into human longevity. - Andrew Parry: Head of Equities, Hermes Investment Management The panel discussion was led by Neil Shah, Head of Research at Edison Research.

Professor Richard Faragher speaks at the Flourishing Lives conference 2017 about the science of ageing and the potential to transform health in later life. Followed by a Q&A with the Flourishing coalition members.